CancerVax Activates Human Killer T-Cells Against Cancer
LEHI, Utah, August 6, 2026 CancerVax announced a significant preclinical milestone with new in vitro findings demonstrating that its...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LEHI, Utah, August 6, 2026 CancerVax announced a significant preclinical milestone with new in vitro findings demonstrating that its...
SAN DIEGO, Calif., July 2, 2026 Arcturus Therapeutics Holdings Inc. announced a strategic collaboration with Thermo Fisher Scientific to...
KYOTO, Japan, June 26, 2026 Nippon Shinyaku Co., Ltd. announced it has entered into an option agreement with Elixirgen...
EDINBURGH & LONDON, UK, June 17, 2026 Resolution Therapeutics announced the expansion of its pipeline for inflammatory and fibrotic...
MENLO PARK, California, May 20, 2026 ReCode Therapeutics announced positive clinical data from its RCT1100 inhaled mRNA therapy program...
